Michael G Agadjanyan
Institute for Molecular Medicine
NIH Rank #1604
- Program Leader
- R01 Holder
- Top 10% Funded
- Early Career
NIH Funding · FY2024
Total Funding
$4M
Fiscal year 2024
Grants Awarded
2
Active NIH grants
National Rank
#1,604
Among 57,894 PIs
First NIH Award
2024
Year of first funding
Funding & rank history
NIH funding totals and national rank by fiscal year.
Single fiscal year on record (FY2024): $4M across 2 grants · National rank #1604.
Top grants by award amount
Michael G Agadjanyan's NIH grant portfolio, ranked by award amount.
- 5R01AG074983-03R01Safety/Tolerability/Immunogenicity of first-in-human Aβ DNA vaccine, AV-1959D Phase 1 trials in early-stage AD subjects: based on IND18953 cleared by FDA.$2.2Maward amount
- 1U01AG084528-01U01IND enabling CMC/safety/toxicology studies, submission of IND and pilot Phase 1 clinical trial with PV-1950R vaccine for Lewy Body Dementia (LBD)$1.8Maward amount
Affiliation
Institutions that have administered grants for Michael G Agadjanyan.
Affiliated with Institute for Molecular Medicine (CA).
Career milestones
Key NIH funding milestones over time.
- 2024First NIH AwardInstitute for Molecular Medicine
- 2024$500K Cumulative Funding
- 2024$1M Cumulative Funding
- 2024$2M Cumulative Funding
- 2024Entered Top 50% NationallyRanked #1604
- 2024Entered Top 25% NationallyRanked #1604
- 2024Entered Top 10% NationallyRanked #1604
Related investigators
Other NIH-funded PIs frequently associated with Michael G Agadjanyan.
Explore further
Find collaborators for Michael G Agadjanyan
Search NIH-funded principal investigators by topic, department, or activity.
Open Find Collaborators →Check S10 eligibility at Institute for Molecular Medicine
Review past S10 Shared Instrumentation Grant awards and equipment categories.
Open S10 Eligibility Finder →Benchmark grant budgets
Compare median NIH grant budgets across departments, mechanisms, and years.
Open Grant Budget Benchmark →